Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook

Stock Track

2025/01/15

Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.

Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.

Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1185789110"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185789110\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185789110?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-15 04:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185789110","market":"hk","top_or_hot":-1,"title":"Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook","media":"Stock Track","content":"<p>Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.</p>\n\n<p>Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.</p>\n\n<p>Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Option Care Health Soars 5% on Price Target Hike and Strong Q4 Revenue Outlook\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-01-15 04:25</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.</p>\n\n<p>Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.</p>\n\n<p>Option Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OPCH","symbol_name":"Option Care Health Inc","start_time":0,"source_url":"","article_id":"1185789110","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185789110","pubTimestamp":1736886306,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Option Care Health Inc  shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.Barrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outl","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OPCH":"Option Care Health Inc"},"translate_title":"股票跟踪期权Care Health因价格目标上调和强劲的第四季度收入前景而飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPCH":1},"content_text":"Option Care Health Inc (OPCH) shares soared 5.01% on Tuesday's intraday trading session, outperforming the broader market. The rally came as analysts raised their price targets and the company issued preliminary Q4 and full-year 2024 results showing robust revenue growth expectations.\nBarrington Research raised its price target on OPCH to $33 from $32, maintaining an Outperform rating on the stock. The analysts cited the company's strong preliminary financial results as the catalyst for the raised outlook.\nOption Care Health expects to report net revenues between $1.34 billion to $1.35 billion for Q4 2024, representing an impressive 19.2% to 20.1% year-over-year growth. For the full year 2024, the company projects net revenues to increase between $5.2 billion to $5.4 billion compared to 2023. These robust top-line growth estimates, driven by the company's strategic initiatives and favorable market conditions, have boosted investor confidence in the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}